Observations refute widely held view on causal mechanism in amyotrophic lateral sclerosis

February 29, 2012, Technische Universitaet Muenchen
This is a microscopic image of a spinal cord section, in which energy-producing organelles (mitochondria) were labeled using a fluorescent protein derived from jellyfish. The nuclei of cells are labled in magenta. The spinal cord is the site of an important class of neurodegenerative diseases ("motor neuron diseases," such as amyotrophic lateral sclerosis, or ALS) -- and disturbed transport or functioning of mitochondria is widely believed to be a causative step in this group of diseases. Credit: Misgeld lab, TU Muenchen

In science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a discovery can save scientists from spending precious years of effort exploring a dead end. In a study published in the Proceedings of the National Academy of Sciences, Munich-based researchers refute a widely accepted hypothesis about a causative step in neurodegenerative conditions. These results deal specifically with animal models of human amyotrophic lateral sclerosis (ALS, aka Lou Gehrig's disease) but also raise questions for research on other neurodegenerative diseases, such as Alzheimer's or Huntington's disease.

One of the ways neurodegenerative diseases manifest themselves is in the loss of axons – essentially, the transmission lines for electrical signals in individual – and synapses, the key sites for communication between them. In the past, such damage has been attributed to deficits in the bidirectional transport of organelles, such as the intracellular power plants called mitochondria, along the axons of nerve cells. Now, researchers at the Technische Universitaet Muenchen (TUM) and Ludwig-Maximilians-Universitaet Muenchen (LMU) have put that assumption under the microscope in the most thorough test to date. They used novel imaging techniques to observe changes in both axon morphology and organelle transport – with high resolution in both space and time – in several different animal models of ALS. Their results show that transport deficits and axon degeneration can develop independently, refuting the that one is a direct cause of the other.

This is a microscopic image of two nerve-muscle synapses in a mouse model of a human motor neuron disease (amyotrophic lateral sclerosis, ALS) in which nerve-muscle contacts break. Energy-producing organelles (mitochondria) were labeled using a fluorescent protein from jellyfish (cyan), while nerve processes are seen as black-grey structures. The nerve-muscle contacts are labeled in red. The upper contact is broken (the black nerve processes have largely lost contact), while the lower looks intact. Credit: Misgeld lab, TU Muenchen

The lead researchers in this study were Prof. Thomas Misgeld of the TUM Institute of Neuroscience, a Fellow of the TUM Institute for Advanced Study, and Prof. Martin Kerschensteiner of the LMU Institute of Clinical Neuroimmunology. Together with Misgeld's research group, they observed axonal organelle transport in living tissue in real time – and in a way that enabled them to track the movement of individual mitochondria – using a novel imaging approach that involves transgenic labeling. They were also able to observe transport of another kind of organelle, endosome-derived vesicles. Several different animal models of ALS were investigated, all of which are based on human mutations associated with the disease.

This movie shows axonal organelle transport in nerve fibers isolated from transgenic mice that express a fluorescent protein in their neuronal mitochondria. The top and bottom are controls (normal, wild type -- WT -- mice and mice overexpressing a non-mutated form of a human ALS-related protein, SOD -- SOD-WT). In the middle are two mouse models of ALS that express two different mutated forms of the human SOD protein (G93A and G85R). As can be seen, there is no clear correlation between the presence of reduced mitochondrial transport (in G93A and SOD-WT) and presence of an ALS-like disease (which both mutations, G93A and G85R, induce). Credit: Petar Marinkovic;, Misgeld lab, TU Muenchen

"The methods – both in terms of labeling and in terms of live microscopy – that Martin Kerschensteiner and I have developed over the past years to track mitochondria in intact axons now allowed our student, Petar Marinković, to look directly into models of ALS," Misgeld explained. "The result came a bit as a surprise, as we fully expected a problem with transport of these organelles would be present in all the disease models and missing in all the controls. Well, the results taught us differently."

The researchers investigated a number of different questions arising from this surprising result, using multiple animal models of ALS and focusing on motor neurons, the kind of neuron most affected in this disease. By comparison, most previous studies of the putative link between organelle transport and ALS had been limited: Some, for example, focused on a single mutation, made their observations in vitro or in non-motor nerve cells, or did not include a wild-type mutation as a control; others measured surrogates for organelle transport deficits instead of observing transport directly.

Among the conclusions: In ALS models, reduction of organelle transport and initiation of axon degeneration appear to be due to different mechanisms. This suggests that, at least for ALS, axonal organelle transport may be an unsuitable therapeutic target.

In addition, Misgeld said, "We do think these insights have implications for other studies of ALS, or even studies of other neurodegenerative diseases. What our experiments really say is that it is not easy to develop faithful models of . So it might be worth spending more effort to get better animal models, as this is the only way forward for mechanistic studies, while always checking them against human pathology or human-derived cellular models. In the meantime, it is probably prudent to work with several of the available models in parallel. Moreover, in more general biological terms, our results also speak to the relationship between axonal transport disruptions and degeneration – which might not be as tight as we assumed. Here we have a lot more to understand."

Explore further: Blocking metabolic protein improves movement in animals with amyotrophic lateral sclerosis

More information: Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Petar Marinković, Miriam S. Reuter, Monika S. Brill, Leanne Godinho, Martin Kerschensteiner, and Thomas Misgeld, PNAS Early Edition, Feb. 27-March 2, 2012. DOI: 10.1073/pnas.1200658109

Related Stories

Blocking metabolic protein improves movement in animals with amyotrophic lateral sclerosis

January 17, 2012
Turning off a protein that helps cells balance energy increases animal mobility and reduces the death of nerve cells that control movement in animal models of amyotrophic lateral sclerosis (ALS), according to a study in the ...

Disease progression halted in rat model of Lou Gehrig's disease

December 12, 2011
Amyotrophic lateral sclerosis (ALS; also known as Lou Gehrig's disease) is an incurable adult neurodegenerative disorder that progresses to paralysis and death. Genetic mutations are the cause of disease in 5% of patients ...

Using bone marrow to protect the brain

September 20, 2011
The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University ...

Recommended for you

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.